2018-2023 Global Travelers Vaccines Consumption Market Report
The report requires updating with new data and is sent in 48 hours after order is placed.
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Travelers Vaccines market for 2018-2023.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
The classification of Travelers Vaccines includes Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine and other vaccines. The proportion of Hepatitis Vaccine in 2016 is about 28.94%, the proportion of Japanese Encephalitis Vaccine in 2016 is about 15.67%, and the proportion of other vaccine in 2016 is about 24.55%.
Travelers Vaccines are application in Tourists, Students, Workers and others. The most of Travelers Vaccines is Tourists, and the market share of that is about 44.41 % in 2016.
North America is the largest consumption place, with a consumption market share nearly 49.42% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 19.41% in 2016. And Asia Pacific in the third largest consumption region with the consumption market share of 18.09%.
Over the next five years, LPI(LP Information) projects that Travelers Vaccines will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Travelers Vaccines market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Research objectives
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Travelers Vaccines market for 2018-2023.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
The classification of Travelers Vaccines includes Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine and other vaccines. The proportion of Hepatitis Vaccine in 2016 is about 28.94%, the proportion of Japanese Encephalitis Vaccine in 2016 is about 15.67%, and the proportion of other vaccine in 2016 is about 24.55%.
Travelers Vaccines are application in Tourists, Students, Workers and others. The most of Travelers Vaccines is Tourists, and the market share of that is about 44.41 % in 2016.
North America is the largest consumption place, with a consumption market share nearly 49.42% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 19.41% in 2016. And Asia Pacific in the third largest consumption region with the consumption market share of 18.09%.
Over the next five years, LPI(LP Information) projects that Travelers Vaccines will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Travelers Vaccines market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
- Meningococcal Vaccine
- Japanese Encephalitis Vaccine
- Yellow Fever Vaccine
- Hepatitis Vaccine
- Cholera Vaccine
- Other
- Tourists
- Students
- Workers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline
- Sanofi Pasteur
- Merck
- Pfizer
- CNBG
- Sanofi Pasteur MSD
- Serum Institute of India
- Biokangtai
Research objectives
- To study and analyze the global Travelers Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
- To understand the structure of Travelers Vaccines market by identifying its various subsegments.
- Focuses on the key global Travelers Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Travelers Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Travelers Vaccines submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Travelers Vaccines Consumption 2013-2023
2.1.2 Travelers Vaccines Consumption CAGR by Region
2.2 Travelers Vaccines Segment by Type
2.2.1 Meningococcal Vaccine
2.2.2 Japanese Encephalitis Vaccine
2.2.3 Yellow Fever Vaccine
2.2.4 Hepatitis Vaccine
2.2.5 Cholera Vaccine
2.2.6 Other
2.3 Travelers Vaccines Consumption by Type
2.3.1 Global Travelers Vaccines Consumption Market Share by Type (2013-2018)
2.3.2 Global Travelers Vaccines Revenue and Market Share by Type (2013-2018)
2.3.3 Global Travelers Vaccines Sale Price by Type (2013-2018)
2.4 Travelers Vaccines Segment by Application
2.4.1 Tourists
2.4.2 Students
2.4.3 Workers
2.4.4 Others
2.5 Travelers Vaccines Consumption by Application
2.5.1 Global Travelers Vaccines Consumption Market Share by Application (2013-2018)
2.5.2 Global Travelers Vaccines Value and Market Share by Application (2013-2018)
2.5.3 Global Travelers Vaccines Sale Price by Application (2013-2018)
3 GLOBAL TRAVELERS VACCINES BY PLAYERS
3.1 Global Travelers Vaccines Sales Market Share by Players
3.1.1 Global Travelers Vaccines Sales by Players (2016-2018)
3.1.2 Global Travelers Vaccines Sales Market Share by Players (2016-2018)
3.2 Global Travelers Vaccines Revenue Market Share by Players
3.2.1 Global Travelers Vaccines Revenue by Players (2016-2018)
3.2.2 Global Travelers Vaccines Revenue Market Share by Players (2016-2018)
3.3 Global Travelers Vaccines Sale Price by Players
3.4 Global Travelers Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Travelers Vaccines Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Travelers Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 TRAVELERS VACCINES BY REGIONS
4.1 Travelers Vaccines by Regions
4.1.1 Global Travelers Vaccines Consumption by Regions
4.1.2 Global Travelers Vaccines Value by Regions
4.2 Americas Travelers Vaccines Consumption Growth
4.3 APAC Travelers Vaccines Consumption Growth
4.4 Europe Travelers Vaccines Consumption Growth
4.5 Middle East & Africa Travelers Vaccines Consumption Growth
5 AMERICAS
5.1 Americas Travelers Vaccines Consumption by Countries
5.1.1 Americas Travelers Vaccines Consumption by Countries (2013-2018)
5.1.2 Americas Travelers Vaccines Value by Countries (2013-2018)
5.2 Americas Travelers Vaccines Consumption by Type
5.3 Americas Travelers Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Travelers Vaccines Consumption by Countries
6.1.1 APAC Travelers Vaccines Consumption by Countries (2013-2018)
6.1.2 APAC Travelers Vaccines Value by Countries (2013-2018)
6.2 APAC Travelers Vaccines Consumption by Type
6.3 APAC Travelers Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Travelers Vaccines by Countries
7.1.1 Europe Travelers Vaccines Consumption by Countries (2013-2018)
7.1.2 Europe Travelers Vaccines Value by Countries (2013-2018)
7.2 Europe Travelers Vaccines Consumption by Type
7.3 Europe Travelers Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Travelers Vaccines by Countries
8.1.1 Middle East & Africa Travelers Vaccines Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Travelers Vaccines Value by Countries (2013-2018)
8.2 Middle East & Africa Travelers Vaccines Consumption by Type
8.3 Middle East & Africa Travelers Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Travelers Vaccines Distributors
10.3 Travelers Vaccines Customer
11 GLOBAL TRAVELERS VACCINES MARKET FORECAST
11.1 Global Travelers Vaccines Consumption Forecast (2018-2023)
11.2 Global Travelers Vaccines Forecast by Regions
11.2.1 Global Travelers Vaccines Forecast by Regions (2018-2023)
11.2.2 Global Travelers Vaccines Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Travelers Vaccines Forecast by Type
11.8 Global Travelers Vaccines Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 GlaxoSmithKline
12.1.1 Company Details
12.1.2 Travelers Vaccines Product Offered
12.1.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 GlaxoSmithKline News
12.2 Sanofi Pasteur
12.2.1 Company Details
12.2.2 Travelers Vaccines Product Offered
12.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Sanofi Pasteur News
12.3 Merck
12.3.1 Company Details
12.3.2 Travelers Vaccines Product Offered
12.3.3 Merck Travelers Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Merck News
12.4 Pfizer
12.4.1 Company Details
12.4.2 Travelers Vaccines Product Offered
12.4.3 Pfizer Travelers Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Pfizer News
12.5 CNBG
12.5.1 Company Details
12.5.2 Travelers Vaccines Product Offered
12.5.3 CNBG Travelers Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 CNBG News
12.6 Sanofi Pasteur MSD
12.6.1 Company Details
12.6.2 Travelers Vaccines Product Offered
12.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Sanofi Pasteur MSD News
12.7 Serum Institute of India
12.7.1 Company Details
12.7.2 Travelers Vaccines Product Offered
12.7.3 Serum Institute of India Travelers Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Serum Institute of India News
12.8 Biokangtai
12.8.1 Company Details
12.8.2 Travelers Vaccines Product Offered
12.8.3 Biokangtai Travelers Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Biokangtai News
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Travelers Vaccines Consumption 2013-2023
2.1.2 Travelers Vaccines Consumption CAGR by Region
2.2 Travelers Vaccines Segment by Type
2.2.1 Meningococcal Vaccine
2.2.2 Japanese Encephalitis Vaccine
2.2.3 Yellow Fever Vaccine
2.2.4 Hepatitis Vaccine
2.2.5 Cholera Vaccine
2.2.6 Other
2.3 Travelers Vaccines Consumption by Type
2.3.1 Global Travelers Vaccines Consumption Market Share by Type (2013-2018)
2.3.2 Global Travelers Vaccines Revenue and Market Share by Type (2013-2018)
2.3.3 Global Travelers Vaccines Sale Price by Type (2013-2018)
2.4 Travelers Vaccines Segment by Application
2.4.1 Tourists
2.4.2 Students
2.4.3 Workers
2.4.4 Others
2.5 Travelers Vaccines Consumption by Application
2.5.1 Global Travelers Vaccines Consumption Market Share by Application (2013-2018)
2.5.2 Global Travelers Vaccines Value and Market Share by Application (2013-2018)
2.5.3 Global Travelers Vaccines Sale Price by Application (2013-2018)
3 GLOBAL TRAVELERS VACCINES BY PLAYERS
3.1 Global Travelers Vaccines Sales Market Share by Players
3.1.1 Global Travelers Vaccines Sales by Players (2016-2018)
3.1.2 Global Travelers Vaccines Sales Market Share by Players (2016-2018)
3.2 Global Travelers Vaccines Revenue Market Share by Players
3.2.1 Global Travelers Vaccines Revenue by Players (2016-2018)
3.2.2 Global Travelers Vaccines Revenue Market Share by Players (2016-2018)
3.3 Global Travelers Vaccines Sale Price by Players
3.4 Global Travelers Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Travelers Vaccines Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Travelers Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 TRAVELERS VACCINES BY REGIONS
4.1 Travelers Vaccines by Regions
4.1.1 Global Travelers Vaccines Consumption by Regions
4.1.2 Global Travelers Vaccines Value by Regions
4.2 Americas Travelers Vaccines Consumption Growth
4.3 APAC Travelers Vaccines Consumption Growth
4.4 Europe Travelers Vaccines Consumption Growth
4.5 Middle East & Africa Travelers Vaccines Consumption Growth
5 AMERICAS
5.1 Americas Travelers Vaccines Consumption by Countries
5.1.1 Americas Travelers Vaccines Consumption by Countries (2013-2018)
5.1.2 Americas Travelers Vaccines Value by Countries (2013-2018)
5.2 Americas Travelers Vaccines Consumption by Type
5.3 Americas Travelers Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Travelers Vaccines Consumption by Countries
6.1.1 APAC Travelers Vaccines Consumption by Countries (2013-2018)
6.1.2 APAC Travelers Vaccines Value by Countries (2013-2018)
6.2 APAC Travelers Vaccines Consumption by Type
6.3 APAC Travelers Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Travelers Vaccines by Countries
7.1.1 Europe Travelers Vaccines Consumption by Countries (2013-2018)
7.1.2 Europe Travelers Vaccines Value by Countries (2013-2018)
7.2 Europe Travelers Vaccines Consumption by Type
7.3 Europe Travelers Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Travelers Vaccines by Countries
8.1.1 Middle East & Africa Travelers Vaccines Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Travelers Vaccines Value by Countries (2013-2018)
8.2 Middle East & Africa Travelers Vaccines Consumption by Type
8.3 Middle East & Africa Travelers Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Travelers Vaccines Distributors
10.3 Travelers Vaccines Customer
11 GLOBAL TRAVELERS VACCINES MARKET FORECAST
11.1 Global Travelers Vaccines Consumption Forecast (2018-2023)
11.2 Global Travelers Vaccines Forecast by Regions
11.2.1 Global Travelers Vaccines Forecast by Regions (2018-2023)
11.2.2 Global Travelers Vaccines Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Travelers Vaccines Forecast by Type
11.8 Global Travelers Vaccines Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 GlaxoSmithKline
12.1.1 Company Details
12.1.2 Travelers Vaccines Product Offered
12.1.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 GlaxoSmithKline News
12.2 Sanofi Pasteur
12.2.1 Company Details
12.2.2 Travelers Vaccines Product Offered
12.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Sanofi Pasteur News
12.3 Merck
12.3.1 Company Details
12.3.2 Travelers Vaccines Product Offered
12.3.3 Merck Travelers Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Merck News
12.4 Pfizer
12.4.1 Company Details
12.4.2 Travelers Vaccines Product Offered
12.4.3 Pfizer Travelers Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Pfizer News
12.5 CNBG
12.5.1 Company Details
12.5.2 Travelers Vaccines Product Offered
12.5.3 CNBG Travelers Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 CNBG News
12.6 Sanofi Pasteur MSD
12.6.1 Company Details
12.6.2 Travelers Vaccines Product Offered
12.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Sanofi Pasteur MSD News
12.7 Serum Institute of India
12.7.1 Company Details
12.7.2 Travelers Vaccines Product Offered
12.7.3 Serum Institute of India Travelers Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Serum Institute of India News
12.8 Biokangtai
12.8.1 Company Details
12.8.2 Travelers Vaccines Product Offered
12.8.3 Biokangtai Travelers Vaccines Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Biokangtai News
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Figure Picture of Travelers Vaccines
Table Product Specifications of Travelers Vaccines
Figure Travelers Vaccines Report Years Considered
Figure Market Research Methodology
Figure Global Travele
Figure Picture of Travelers Vaccines
Table Product Specifications of Travelers Vaccines
Figure Travelers Vaccines Report Years Considered
Figure Market Research Methodology
Figure Global Travele
